HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Linda Lanting Selected Research

Inflammation (Inflammations)

1/2023Palmitic Acid-Induced Long Noncoding RNA PARAIL Regulates Inflammation via Interaction With RNA-Binding Protein ELAVL1 in Monocytes and Macrophages.
12/2022miR-379 mediates insulin resistance and obesity through impaired angiogenesis and adipogenesis regulated by ER stress.
1/2020Novel Long Noncoding RNA, Macrophage Inflammation-Suppressing Transcript (MIST), Regulates Macrophage Activation During Obesity.
12/2018A Novel Angiotensin II-Induced Long Noncoding RNA Giver Regulates Oxidative Stress, Inflammation, and Proliferation in Vascular Smooth Muscle Cells.
1/2018Diabetes Mellitus-Induced Long Noncoding RNA Dnm3os Regulates Macrophage Functions and Inflammation via Nuclear Mechanisms.
2/2005Effects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Linda Lanting Research Topics

Disease

18Diabetic Nephropathies (Diabetic Nephropathy)
01/2023 - 11/2003
13Hypertrophy
01/2018 - 03/2002
8Atherosclerosis
11/2017 - 06/2003
6Inflammation (Inflammations)
01/2023 - 02/2005
6Hypertension (High Blood Pressure)
10/2021 - 06/2003
5Diabetes Complications
01/2021 - 09/2003
4Obesity
01/2023 - 04/2005
4Proteinuria
02/2014 - 04/2005
3Diabetes Mellitus
01/2018 - 01/2005
3Albuminuria
08/2008 - 01/2005
2Insulin Resistance
12/2022 - 04/2005
2Diabetic Angiopathies (Diabetic Angiopathy)
02/2014 - 05/2006
2Fibrosis (Cirrhosis)
03/2012 - 07/2009
1Hyperinsulinism (Hyperinsulinemia)
12/2022
1Cardiovascular Diseases (Cardiovascular Disease)
05/2012
1Kidney Diseases (Kidney Disease)
08/2011
1Body Weight (Weight, Body)
08/2008
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2008
1Type 2 Diabetes Mellitus (MODY)
10/2007

Drug/Important Bio-Agent (IBA)

11MicroRNAs (MicroRNA)IBA
01/2023 - 08/2011
7Long Noncoding RNAIBA
01/2023 - 12/2014
7Angiotensin IIIBA
12/2018 - 03/2002
6Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA
08/2008 - 06/2003
4Proteins (Proteins, Gene)FDA Link
12/2014 - 03/2002
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2017 - 09/2004
3CollagenIBA
12/2014 - 02/2007
3Fibronectins (Fibronectin)IBA
03/2012 - 03/2002
3Extracellular Matrix ProteinsIBA
10/2010 - 12/2006
3AcidsIBA
08/2008 - 03/2002
2Insulin (Novolin)FDA Link
12/2022 - 12/2014
2OligonucleotidesIBA
09/2016 - 10/2007
2alpha2 Subunit Collagen Type IIBA
12/2014 - 10/2010
2ChromatinIBA
02/2014 - 06/2013
2Losartan (Cozaar)FDA LinkGeneric
02/2014 - 04/2005
2Histones (Histone)IBA
02/2014 - 06/2013
2Phosphotransferases (Kinase)IBA
08/2013 - 07/2009
2LipidsIBA
03/2008 - 03/2002
2Advanced Glycation End ProductsIBA
07/2006 - 09/2003
2LigandsIBA
07/2006 - 05/2006
2Oxidants (Oxidizing Agents)IBA
05/2006 - 02/2005
2EnzymesIBA
04/2005 - 11/2003
2Lipoxygenase (Lipoxygenase-1)IBA
11/2003 - 03/2002
1RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2023
1Nonesterified Fatty Acids (NEFA)IBA
01/2023
1Palmitic Acid (Hexadecanoic Acid)IBA
01/2023
1Transcription Factor CHOPIBA
12/2022
1oxidized low density lipoproteinIBA
01/2020
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
12/2018
1NucleolinIBA
01/2018
1Collagen Type I (Type I Collagen)IBA
12/2014
1Lysine (L-Lysine)FDA Link
02/2014
1Type 1 Angiotensin ReceptorIBA
02/2014
1Plasminogen Activator Inhibitor 1IBA
02/2014
1Plasminogen Activators (Plasminogen Activator)IBA
03/2013
1locked nucleic acidIBA
03/2012
1ChemokinesIBA
03/2010
1Transforming Growth Factor beta (TGF-beta)IBA
07/2009
1Transforming Growth Factor beta1 (TGF beta 1)IBA
07/2009
1Streptozocin (Streptozotocin)FDA Link
08/2008
1Cyclin-Dependent Kinases (cdk Proteins)IBA
08/2008
1Small Interfering RNA (siRNA)IBA
08/2008
1CholesterolIBA
08/2008
1Connective Tissue Growth FactorIBA
10/2007
1CreatinineIBA
10/2007
1NF-kappa B (NF-kB)IBA
07/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2006
1src-Family KinasesIBA
05/2006
1Receptor for Advanced Glycation End ProductsIBA
05/2006
1Interleukin-18 (Interleukin 18)IBA
05/2005
112-Hydroxy-5,8,10,14-eicosatetraenoic AcidIBA
01/2005
1Lipoxygenase InhibitorsIBA
01/2005
1Hydroxyeicosatetraenoic Acids (HETE)IBA
01/2005
14- (3- (biotinylaminohexamethylenaminocarbonyl)propanoylaminomethyl)- 2- methyl- 1,3- dithiolane- 2- yl- (Ala(7))phalloidinIBA
01/2005
1Transcription Factors (Transcription Factor)IBA
06/2003
1Mitogen-Activated Protein KinasesIBA
06/2003
1Arachidonic Acid (Vitamin F)IBA
03/2002
1Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA
03/2002
1p38 Mitogen-Activated Protein KinasesIBA
03/2002
14- (4- fluorophenyl)- 2- (4- hydroxyphenyl)- 5- (4- pyridyl)imidazoleIBA
03/2002
1Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
03/2002

Therapy/Procedure

6Therapeutics
12/2022 - 12/2010